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Abstract 
Diabetic ulcers seem to be arrested in the inflammatory/proliferative stage of the healing 
process, allowing infection and inflammation to preclude healing. Antibiotic-resistant bacteria 
have become a major cause of infections, including diabetic foot infections. It is proposed here 
that the modern developments of an ancient and traditional treatment for wounds, dressing 
them with honey, provide the solution to the problem of getting diabetic ulcers to move on from 
the arrested state of healing. Honeys selected to have a high level of antibacterial activity have 
been shown to be very effective against antibiotic-resistant strains of bacteria in laboratory and 
clinical studies. The potent anti-inflammatory action of honey is also likely to play an important 
part in overcoming the impediment to healing that inflammation causes in diabetic ulcers, as is 
the antioxidant activity of honey. The action of honey in promotion of tissue regeneration 
through stimulation of angiogenesis and the growth of fibroblasts and epithelial cells, and its 
insulin-mimetic effect, would also be of benefit in stimulating the healing of diabetic ulcers. The 
availability of honey-impregnated dressings which conveniently hold honey in place on ulcers 
has provided a means of rapidly debriding ulcers and removing the bacterial burden so that 
good healing rates can be achieved with neuropathic ulcers. With ischemic ulcers, where 
healing cannot occur because of lack of tissue viability, these honey dressings keep the ulcers 
clean and prevent infection occurring. 
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In the recently published paper “What is the future of diabetic wound care?”1 the authors give an 
excellent review of the reasons why diabetic wounds do not heal, and provide data on the 
magnitude of the problem this causes. They point out that many of the nearly 2 million cases of 
chronic diabetic foot ulcers in the USA ultimately result in amputation, with a 2-year survival rate 
after these amputations of only 50%–60%. They then go on to discuss at length the need for 
new smart matrix therapies, and how the development of these will require a multidisciplinary 
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translational research approach. Considering that the research on tissue-engineered skin 
substitutes was started approximately 20 years ago yet this form of therapy has barely started to 
get into regular clinical practice, there is obviously an immediate need for an effective therapy 
for chronic diabetic ulcers. It is proposed here that the modern developments of an ancient and 
traditional treatment for wounds, dressing them with honey, have allowed this immediate need 
to be met. 
 
Historical usage of honey 
The ancient Egyptians, Assyrians, Chinese, Greeks and Romans all used honey, in combination 
with herbs and on its own, to treat wounds.2 Aristotle (c.350 BC) wrote of honey being a salve 
for wounds and sore eyes,
61 
3 and Dioscorides (c.50 AD) wrote of honey being “good for sunburn 
and spots on the face” and “for all rotten and hollow ulcers”.
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4 The usage of honey has continued 
into present-day folk-medicine; for example, it is a traditional therapy for infected leg ulcers in 
Ghana.
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5 In recent times It has been "rediscovered" by the medical profession,2 possibly 
because the "antibiotic era" is coming to an end as increasing numbers of bacterial strains 
develop resistance to antibiotics.
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Modern clinical evidence for the effectiveness of honey 
The clinical evidence in support of the effectiveness of honey in wound care has been 
comprehensively reviewed.7 This review summarises the findings of 17 randomised controlled 
trials involving a total of 1965 participants, and 5 clinical trials of other forms involving 97 
participants treated with honey. All of these found that honey was more effective than the 
conventional wound care practices used as controls, other than one trial on burns where, only in 
respect of control of infection, was early surgical tangential incision found to be more effective 
than dressing the wounds with honey. The review also summarises the findings 16 trials on a 
total of 533 wounds on experimental animals, where again honey was found to be more 
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effective than the controls in assisting wound healing. There is also summarised a large amount 
of evidence in the form of case studies that have been reported. Ten publications have reported 
on multiple cases, totalling 276 cases. There are also 35 reports of single cases.
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7 This evidence 
is far greater than that for modern wound dressings. It is possibly the myriad of advertisements 
for modern wound dressings, and little for honey, that gives clinicians the impression that there 
is much evidence is behind the modern dressings and none behind honey, when in fact only 
poor-quality trials exist to support the modern wound dressings that are in use.
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8 Perhaps the 
most heavily advertised wound dressings are the nanocrystalline silver dressings, but if the 
PubMed database is searched for evidence to support their use it can be seen that there is in 
fact very little good clinical evidence that has been published other than two recent trials. A 
conclusion reached in a recent systematic review of publications on the use of advanced 
dressings in the treatment of pressure ulcers has found that their generalised use in the 
treatment of pressure ulcers is not supported by good research evidence.
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9 There is now a 
general movement towards evidence-based medicine. In this, decisions should be made on the 
basis of the available evidence. If randomised controlled trials of the highest quality have not 
been conducted, then it is necessary to consider evidence of a lower quality. Advertising, other 
than that which presents good clinical evidence, should not be allowed to influence decisions. 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
 
Usage of honey on diabetic ulcers 
Although there is a vast amount of literature reporting the effectiveness of honey in healing 
wounds, there has been little published specifically on the treatment of diabetic foot ulcers with 
honey. Diabetic ulcers are chronic wounds, and there is a large amount of evidence for the 
effectiveness of honey on chronic wounds. Seven clinical trials, with a total of 255 participants, 
have been conducted using honey on chronic wounds, with positive results for honey being 
reported from all of these.7 There have also been more than one hundred case reports of honey 
being more effective than conventional treatment for chronic wounds.
102 
7 Diabetic ulcers were 103 
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included in one report in the list of recalcitrant wounds and ulcers of varied aetiology that 
“showed remarkable improvement” when treated with honey. These were all wounds showing 
no signs of healing, or were increasing in size, after 1–24 months of conventional treatment.
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10 In 
another report, on using honey to treat septic wounds, chronic ulcers, burns, and pyogenic 
abscesses, 6 patients were diabetic, 5 having a septic foot and 1 with an abscess in the thigh.
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Healing time was 7, 10, 14 and 30 days for four the foot wounds, 15 days for the abscess, and 
no improvement after 56 days for a foot wound on one patient who was ill. Another report, on a 
single case, was on treatment of diabetic foot ulcers, 8 x 5 cm and 3 x 3 cm, on a 79 year old 
patient.
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12 The ulcers remained unhealed after 14 months treatment with an orthotic device, 
antibiotics, topical therapies by a wound care expert and four lots of surgery. MRSA, VRE and 
Pseudomonas were present in wound tissue. After commencing treatment with honey, the 
ulcers were granulating within 2 weeks, and healed within 6 and 12 months. Two years later the 
ulcers had not recurred. Although honey gave healing of these ulcers where nothing else had 
worked, the healing was still fairly slow. This possibly because “supermarket honey” was used, 
which is honey that is usually processed in a way that destroys all of the antibacterial activity 
and possibly removes other beneficial components. In the other two reports unprocessed honey 
was used, which would have had its therapeutic properties undamaged. 
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Antibacterial activity of honey 
There have been many publications on laboratory studies showing that honey has very broad 
spectrum antibacterial activity.13 But most of these do not take into account that honeys can 
vary as much as 100-fold in the potency of their antibacterial activity.
124 
14 Only in the more recent 
publications was the testing of the sensitivity of various species of bacteria to honey done using 
honeys selected to have antibacterial potency near the median level found in surveys of large 
numbers of samples. Laboratory studies with Manuka (Leptospermum scoparium) honey with 
antibacterial potency near the median level for active Manuka honey have shown the MIC 
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(minimum inhibitory concentration, i.e. the concentration down to which honey could be diluted 
by wound exudate and still prevent bacterial growth) to be 2–3% for Staphylococcus aureus,
130 
15 
3.3–4% for coagulase-negative staphylococci,
131 
16 5.5–9% for Pseudomonads,17, 18 2.7–3% for 
MRSA,
132 
19 and 3.8–5% for VRE.19 The antibacterial potency of the honeys used in the various 
honey wound-care products now on sale manufactured from Leptospermum honey (Manuka 
honey and Jellybush honey) is higher than that of the honey used these studies, but there are 
other wound-care products manufactured from honeys not selected to have high levels of 
antibacterial activity.
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Another consideration is the type of antibacterial activity in honey. Most honeys owe their 
antibacterial activity (beyond that just due to the osmotic effect of the high sugar content) to the 
production of hydrogen peroxide by an enzyme that the bees secrete into the nectar harvested 
to make honey.13 But some Manuka and Jellybush honeys have also a high activity due to a 
phytochemical antibacterial component which comes from the nectar of some varieties of 
Leptospermum. Although in laboratory testing the MIC values recorded are near the same for 
mid-range honeys of either type, this would not be the case on a wound. There is in wound fluid, 
and more so the cells in wound tissues, the enzyme catalase which rapidly breaks down 
hydrogen peroxide, so honeys other than the Leptospermum ones would have their antibacterial 
activity greatly decreased. Also to be noted is that all types of honey vary from batch to batch in 
their antibacterial potency. Much of the Manuka and Jellybush honey on sale as a food item has 
little or none of the phytochemical antibacterial component, but the Leptospermum honey on 
sale as medical products has standardised high levels of it. 
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Why honey works well on diabetic ulcers 
A wound will not heal if it is infected. Toxins produced by bacteria can stop the growth of cells 
which repair the wound. Bacterial proteases can digest away the matrix necessary for tissue 
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replacement, and digest cell growth factors. Also, components of the outer coat of the bacteria 
can stimulate a strong inflammatory response and the resultant inflammation then prevents 
healing and if severe can activate proteases to cause ulceration. Foot infections are a serious 
complication of diabetes and a leading cause of diabetes-related hospitalizations. Amputation 
may be needed when infections fail to respond to therapy. The development by bacteria of 
resistance to antibiotics has become a major global problem. Methicillin-resistant 
Staphylococcus aureus (MRSA) has become a major cause of infections, including diabetic foot 
infections. Initially it was associated only with hospital-acquired infections, but now is also a 
problem in the community. The effectiveness of honey in clinical usage in clearing infection with 
MRSA
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12, 21-24 and VRE12 has been reported. As well the antibacterial action, there have been 
many reports of honey having a rapid debriding effect, which painlessly lifts off slough and 
necrotic tissue (which are reservoirs of bacteria on the wound), making surgical debridement 
unnecessary.
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Diabetic ulcers, instead of going through the normal four overlapping stages of healing, 
hemostasis, inflammation, proliferation and remodelling, seem instead to be arrested in the 
inflammatory/proliferative process.1 This allows for infection and inflammation, which preclude 
healing. The potent anti-inflammatory action of honey is likely to play an important part in 
overcoming this impediment to healing in diabetic ulcers. The anti-inflammatory action of honey 
was noted by Dioscorides two millennia ago, who wrote of honey being good for sun-burn,
172 
173 
174 
4 and 
since then a large amount of clinical and histological evidence for it has accumulated, which has 
been reviewed.
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26 The anti-inflammatory action of honey would decrease the excessive activity 
of collagenase and elastase, a feature of inflammatory conditions and which causes the 
premature degradation of collagen and growth factors in chronic wounds.
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1 A characteristic of 
the extracellular matrix in wounds in diabetes is the presence of advanced glycation and 
lipoxidation end products which stimulate oxidative stress and inflammation in wounds.
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excellent antioxidant properties of honey would be beneficial in counteracting these effects. It is 
of note in this respect that another advantage of using active Manuka honey instead of other 
types of honey is that it does not generate hydroxide free radicals like honey with antibacterial 
activity due to hydrogen peroxide does, and rapidly quenches any formed by the Fenton 
reaction.
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The good results achieved on diabetic ulcers with honey may also be due to honey directly 
moving the wounds on from the arrested state of healing. It has been observed that honey 
promotes tissue regeneration through stimulation of angiogenesis and the growth of fibroblasts 
and epithelial cells.25  191 
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The slow healing rates seen in diabetic wounds could also be due to lack of insulin or lack of 
responsiveness to insulin. As well as regulating the uptake of glucose into cells, insulin 
functions as a growth hormone, and it has been shown that intravenous infusion or topical 
application of insulin improves the rate of wound healing.28-30 Honey has an insulin-mimetic 
effect: when administered by inhalation as an aerosol, honey significantly reduced random 
blood glucose (measured 30 min after inhalation), significantly reduced the fasting blood 
glucose level (3 hours after inhalation), and the intensity of hyperglycemia was significantly 
lowered in the glucose tolerance test after honey inhalation.
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Modern developments in the usage of honey 
In the “rediscovery” of the use of honey for wound care there has been a lack of awareness of 
some ancient wisdom. Four millennia ago the Ancient Egyptians mixed cotton fibres and fat into 
honey to create a dressing that would hold the honey on a wound.32 It is necessary to create a 
retentive dressing of some sort, because at body temperature honey becomes very runny and 
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flows off a wound. It takes very little dilution of honey with wound exudate to make the honey 
very watery. The water content of honey is bound up on the sugar molecules in honey, so it 
does not easily wet absorbent dressing materials. This means that if honey is applied to a 
wound, whether directly or placed on an absorbent dressing, when the dressing is held on the 
wound the honey tends to be squeezed out laterally. To get the honey to be retained well on the 
wound it needs to be soaked into the absorbent dressing before it is applied. Various sorts of 
such honey-impregnated dressings are now available as sterile medical products.
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In our initial work on clinical use of honey dressings we used a Gamgee type of dressing 
impregnated with honey. We found that with heavily exuding wounds it was necessary to 
change the dressing up to three times a day, as the exudate flushed the honey from the side of 
the dressing facing the wound to the outside of the dressing pad or even right through it and into 
the secondary dressing. This left no honey in contact with the wound bed, with the consequence 
that healing was slow, adhesion of the dressings occurred, and maceration of skin around the 
wound occurred. This situation was greatly improved when we changed to using a honey-
impregnated alginate fibre dressing pad instead, as the alginate fibres transform to a gel when 
wound exudate is absorbed into them. (This also has the advantage of the hemostatic 
properties of alginate.) Thus the honey is held in a soft gel in contact with the wound bed rather 
than being flushed into the secondary dressing, so less frequent changes of dressings are 
needed. By keeping sufficient honey in contact with the wound bed, by changing the dressings 
frequently enough to cope with the level of exudate, the level of exudate will decrease because 
of the anti-inflammatory activity of honey. Less frequent dressing changes will be needed then. 
However, if dressings are not changed frequently enough and the honey is washed away, then 
the anti-inflammatory activity will also be washed away and the wound will remain highly 
exudative. Another form of dressing has been developed in which the honey is combined with 
sodium alginate to gel it, giving a rubbery material which swells as it absorbs exudate.33 This 233 
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has a massive capacity to absorb exudate without the honey being flushed from the wound bed. 
Commercialisation of this dressing is proceeding, and it is expected to be available for clinical 
evaluation soon. 
 
By updating the ancient wisdom of using a honey selected as the best for medical use (we use 
active Manuka honey with a high level of the non-peroxide antibacterial activity that is unique to 
Leptospermum honey, processed with minimal heating to avoid damaging its therapeutic 
properties) and creating a dressing material to hold the honey in place on the wound (we use 
alginate dressings pads impregnated with this honey) we have been able to get very good 
results with diabetic ulcers. We use honey dressings on neuropathic foot ulcers where despite 
pressure off-loading healing is inhibited by the presence of Pseudomonas and Staphylococcus 
aureus. We use these dressings to debride the ulcers and reduce the bacterial burden. Good 
healing rates are then achieved. With ischaemic foot ulcers, where healing cannot occur 
because of lack of tissue viability, we use honey dressings to prevent infection of these ulcers 
whilst waiting for re-vascularisation to be carried out. We find that if there is enough blood flow 
then diabetic ulcers which are due to a combination of ischemia and neuropathy will heal with 
off-loading of pressure. We find that honey is particularly useful for diabetic ulcers that are 
otherwise difficult to debride particularly where bacterial loading may be a confounding factor in 
the creation of slough. 
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